Marcel Behr appointed interim director McGill Interdisciplinary Initiative in Infection and Immunity
Founding director Don Sheppard to direct Antimicrobial Resistance Task Force at the Public Health Agency of Canada
Dr. Marcel Behr was appointed interim director of the McGill Interdisciplinary Initiative in Infection and Immunity (MI4), Faculty of Medicine and Health Sciences, McGill University, in November 2021. The co-director (Infection) of MI4 prior to this appointment, he will continue to work with Dr. Marie Hudson, also a co-director (Immunity) since 2019.
Read more about Dr. Behr’s appointment and MI4 on the McGill website.
Ben Geboe awarded the 2021-2022 Dr. Margaret Becklake Fellowship for research with urban Indigenous populations
The RI-MUHC postdoc is working on a culturally safe framework for TB prevention and care for Indigenous populations in Montreal
Read article here
Regular screening for tuberculosis in Inuit communities is cost-effective
A new study from RI-MUHC researchers published in CMAJ recommends regular screening to help reduce outbreaks
Dr. Kevin Schwartzman, Senior Scientist in the Translational Research in Respiratory Diseases Program at the RI-MUHC and first author Aashna Uppal, MScPH.
Read article here
Tuberculosis Trials Consortium Clinical (2020-2030)
RI-MUHC is being awarded the Tuberculosis Trials Consortium Clinical from the Centers for Disease Control and Preventions (CDC) in the amount of $USD 13.5 million.
The purpose of this procurement is to support clinical trials and clinical research on the treatment, diagnosis and prevention of tuberculosis . Emphasis will be given to studies of latent TB infection in low- and medium- TB incidence settings, inclusive of but not limited to the United States and Canada, as well as studies of active TB disease both domestically and internationally.
More information on the TBTC can be found here.
TB Centre Members Awarded 4-year CIHR Project Grant
Dr. Simon Grandjean Lapierre (PI), Dr. Marcel Behr (Co-I) and Dr. Kevin Schwartzman (Co-I) have been awarded a 4-year project grant from the Canadian Institutes of Health Research for their project titled “Tuberculosis Whole Genome Sequencing for Disease Control in Madagascar - A Cluster Randomized Controlled Trial to Evaluate Different Community-Level Strategies to Reduce the Burden of Disease”.
Some of our Award-winning Investigators
-
Dr Dick Menzies
Dr. Dick Menzies, Director of the Respiratory Epidemiology Unit at McGill and McGill’s World Health Organization Collaborating Centre in TB Research, has been named recipient of the 2019 CIHR-ICRH/CTS Distinguished Lecturer Award (DLA) in Respiratory Sciences.
Each year, the DLA Series honours outstanding researchers within the Institute of Circulatory and Respiratory Health (ICRH) research community who have contributed significantly to the advancement of science in their field both in Canada and internationally.
-
Dr Marcel Behr
Dr. Marcel Behr has been elected to Fellowship in the American Academy of Microbiology. The Academy recognizes excellence, originality, and leadership in the microbiological sciences.
He has also been elected as Tier 1 Canada Research Chair for Mycobacterial Genomics.
Tier 1 Canada Research Chairs (CRC) are for outstanding researchers acknowledged by their peers as world leaders in their fields. A Chair is tenable for seven years and renewable once.
-
Dr Madhukar Pai
Dr. Madhukar Pai serves as a Consultant to the Bill & Melinda Gates Foundation. He serves on the Scientific Advisory Committee of FIND, Geneva; and Access Advisory Committee of TB Alliance. He is on the editorial boards of Lancet Infectious Diseases, PLoS Medicine, eLife, PLoS ONE, International Journal of TB and Lung Disease, among others.
He is a member of the Royal Society of Canada, and an elected Fellow of the Canadian Academy of Health Sciences.
